KEEPING HIV DRUGS OUT OF THE UK

Glaxo discovered that retroviral drugs sold under the trade marks EPIVIR, COMBIVIR and TRIZIVIR and intended for French West Africa under a not-for-profit scheme were reaching the UK via Dowelhurst, a parallel trader. Glaxo pressed for summary judgment for trade mark infringement, seeking injunctive relief. Dowelhurst expressed anxieties concerning the form of the injunction since it could still source those drugs from elsewhere in the European Union and lawfully import them into the UK. Peter Prescott QC, sitting as an additional judge of the Chancery Division, granted full injunctive relief so far as the drugs destined for Africa were concerned, but agreed that the form of injunction should not be such as to prevent Dowelhurst importing and selling drugs lawfully.

On AIDS in French West Africa click here


KEEPING HIV DRUGS OUT OF THE UK <strong>KEEPING HIV DRUGS OUT OF THE UK</strong> Reviewed by Jeremy on Sunday, August 03, 2003 Rating: 5

No comments:

All comments must be moderated by a member of the IPKat team before they appear on the blog. Comments will not be allowed if the contravene the IPKat policy that readers' comments should not be obscene or defamatory; they should not consist of ad hominem attacks on members of the blog team or other comment-posters and they should make a constructive contribution to the discussion of the post on which they purport to comment.

It is also the IPKat policy that comments should not be made completely anonymously, and users should use a consistent name or pseudonym (which should not itself be defamatory or obscene, or that of another real person), either in the "identity" field, or at the beginning of the comment. Current practice is to, however, allow a limited number of comments that contravene this policy, provided that the comment has a high degree of relevance and the comment chain does not become too difficult to follow.

Learn more here: http://ipkitten.blogspot.com/p/want-to-complain.html

Powered by Blogger.